These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17616687)

  • 1. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage.
    Yamane K; Schupp JE; Kinsella TJ
    Cancer Res; 2007 Jul; 67(13):6286-92. PubMed ID: 17616687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR-Chk1 pathway.
    Yamane K; Taylor K; Kinsella TJ
    Biochem Biophys Res Commun; 2004 May; 318(1):297-302. PubMed ID: 15110787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casein kinase 2 regulates both apoptosis and the cell cycle following DNA damage induced by 6-thioguanine.
    Yamane K; Kinsella TJ
    Clin Cancer Res; 2005 Mar; 11(6):2355-63. PubMed ID: 15788687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells.
    Yan T; Berry SE; Desai AB; Kinsella TJ
    Clin Cancer Res; 2003 Jun; 9(6):2327-34. PubMed ID: 12796402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-tumor cells from an MSH2-null individual show altered cell cycle effects post-UVB.
    Narine KA; Felton KE; Parker AA; Tron VA; Andrew SE
    Oncol Rep; 2007 Dec; 18(6):1403-11. PubMed ID: 17982623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
    Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
    Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for mismatch repair in control of DNA ploidy following DNA damage.
    Strathdee G; Sansom OJ; Sim A; Clarke AR; Brown R
    Oncogene; 2001 Apr; 20(15):1923-7. PubMed ID: 11313940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erybraedin C and bitucarpin A, two structurally related pterocarpans purified from Bituminaria bituminosa, induced apoptosis in human colon adenocarcinoma cell lines MMR- and p53-proficient and -deficient in a dose-, time-, and structure-dependent fashion.
    Maurich T; Iorio M; Chimenti D; Turchi G
    Chem Biol Interact; 2006 Feb; 159(2):104-16. PubMed ID: 16271357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase.
    Franchitto A; Pichierri P; Piergentili R; Crescenzi M; Bignami M; Palitti F
    Oncogene; 2003 Apr; 22(14):2110-20. PubMed ID: 12687013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
    Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
    Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation.
    Davis TW; Wilson-Van Patten C; Meyers M; Kunugi KA; Cuthill S; Reznikoff C; Garces C; Boland CR; Kinsella TJ; Fishel R; Boothman DA
    Cancer Res; 1998 Feb; 58(4):767-78. PubMed ID: 9485033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven.
    Wiltshire T; Senft J; Wang Y; Konat GW; Wenger SL; Reed E; Wang W
    Mol Pharmacol; 2007 Apr; 71(4):1051-60. PubMed ID: 17229870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells.
    Larson JS; Tonkinson JL; Lai MT
    Cancer Res; 1997 Aug; 57(16):3351-5. PubMed ID: 9269994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
    Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
    Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BNIP3 is essential for mediating 6-thioguanine- and 5-fluorouracil-induced autophagy following DNA mismatch repair processing.
    Zeng X; Kinsella TJ
    Cell Res; 2010 Jun; 20(6):665-75. PubMed ID: 20368736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of geno- and cytotoxicity of methylnitrosourea on MMR-proficient and MMR-deficient human tumor cell lines].
    Tronov VA; Kramarenko II; Smirnova TD; Terekhov SM
    Tsitologiia; 2006; 48(1):19-27. PubMed ID: 16568831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BRCT domain is a phospho-protein binding domain.
    Yu X; Chini CC; He M; Mer G; Chen J
    Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA mismatch repair initiates 6-thioguanine--induced autophagy through p53 activation in human tumor cells.
    Zeng X; Yan T; Schupp JE; Seo Y; Kinsella TJ
    Clin Cancer Res; 2007 Feb; 13(4):1315-21. PubMed ID: 17317843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation.
    Fritzell JA; Narayanan L; Baker SM; Bronner CE; Andrew SE; Prolla TA; Bradley A; Jirik FR; Liskay RM; Glazer PM
    Cancer Res; 1997 Nov; 57(22):5143-7. PubMed ID: 9371516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.